SBM's guest contributor and ophthalmologist, Dr. DAvid Weinberg, provides an update on the phase 3 trials of pegcetacoplan for macular degeneration. The results are still disappointing.
The post Pegcetacoplan (Syfovre™) for macular degeneration: an update first appeared on Science-Based Medicine.from Science-Based Medicine https://sciencebasedmedicine.org/pegcetacoplan-syfovre-for-macular-degeneration-an-update/?utm_source=rss&utm_medium=rss&utm_campaign=pegcetacoplan-syfovre-for-macular-degeneration-an-update
No comments:
Post a Comment